Literature DB >> 6368616

Distribution of enkephalin in human fetus and infant spinal cord: an immunofluorescence study.

Y Charnay, C Paulin, F Dray, P M Dubois.   

Abstract

The distribution of enkephalin-like immunoreactivity in the human fetus and infant spinal cord have been studied by indirect immunofluorescence. Enkephalin-like immunoreactive fibers were detectable in the lateral funiculus of fetal spinal cord as early as 10 weeks. At the other fetal ages examined, ranging from 12 to 28 weeks, and in infant, enkephalinlike immunoreactivity was found widely distributed throughout the whole spinal cord. In fetus spinal cord several enkephalin-like immunoreactive cells were sometimes seen scattered in the intermediate gray region. Most of the labeling was, however, represented by thin, varicose, immunofluorescent fibers mainly localized in the intermediate gray regions, in the ventral horn and in the superficial dorsal horn layers where they progressively increased in number. Further, the white matter exhibited enkephalin-like immunoreactive fibers particularly in the lateral funiculus where a dense punctiform immunofluorescence could be seen. On the whole, similar patterns were also visible in infant spinal cord. Thus, the superficial layers of the dorsal horn and the intermediolateral and reticular nuclei areas displayed dense plexuses of immunoreactive fibers. In contrast, the white matter showed only little labeling. In addition, no immunoreactivity was found in fetus and infant dorsal root ganglia. Our results emphasize the wide distribution of the enkephalin-like immunoreactivity in the fetus as in the infant spinal cord and further suggest its first appearance early in fetal life, possibly at the embryonic stage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368616     DOI: 10.1002/cne.902230307

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  7 in total

1.  Mu opioid receptors in developing human spinal cord.

Authors:  S B Ray; S Wadhwa
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

Review 2.  Neuropeptide gene expression and neural activity: assessing a working hypothesis in nucleus caudalis and dorsal horn neurons expressing preproenkephalin and preprodynorphin.

Authors:  G R Uhl; T Nishimori
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

Review 3.  Pain and analgesia in the newborn.

Authors:  M Fitzgerald; N McIntosh
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

4.  Ultrastructure of marginal zone during prenatal development of human spinal cord.

Authors:  T A Rizvi; S Wadhwa; R D Mehra; V Bijlani
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Synenkephalin in bovine and human spinal cord.

Authors:  J Schoenen; F Lotstra; D Liston; J Rossier; J J Vanderhaeghen
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

6.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

7.  [Pain in the fetus: neurobiological, psychophysiological and behavioral aspects.].

Authors:  M Zimmermann
Journal:  Schmerz       Date:  1991-09       Impact factor: 1.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.